German drugmaker BioNTech on Wednesday announced that the European Union will buy an additional 200 million doses of its Coronavirus vaccine, that will be delivered in the second quarter of 2021.
“We will initiate production at our Marburg facility this month and have strengthened our manufacturing network with additional partners. We are continuing to evaluate, together with governments, authorities, and partners at all levels, how we might address an even higher future supply requirement fo…
This story is part of New Europe’s Premium content.
|To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑|